The World Health Organization (WHO) has approved emergency use of AstraZeneca and Oxford University’s Kovid-19 vaccine. Along with this, with the help of WHO to deal with the epidemic, millions of doses will be reached in countries around the world. The United Nations health agency said in a statement on Monday that it had granted emergency approval to the Estrogena vaccine being made by the Serum Institute of India and South Korea’s AstraZeneca-SKBayo.
With the approval of WHO by AstraZeneca’s Kovid-19 vaccine, it will be able to reach the dose in poor countries. Let us tell you that in the vaccine which has been approved for emergency use all over the world, one vaccine makes a serum institute in India. While another South Korean company is making. The WHO chief said that the vaccine would now be available to the entire world under the Kovacs program.
Let us know that the Kovishield vaccine prepared by the Serum Institute has been given the green signal by India for emergency use. In India, this vaccine, as well as the covacine produced by Bharat Biotech, which is completely indigenous, has been approved for emergency use. Vaccination program has also started in India with these two vaccines.
Health Minister Harsh Vardhan said on Monday that 18-19 vaccine companies are busy preparing vaccines for Kovid-19 and they are in various stages of initial testing. He said that we hope that in the coming months we will be able to offer new vaccines in India.
Warning about fake vaccine in Europe
OLAF, the anti-fraud arm of the European Union (EU), has warned 27 member states to beware of fraudsters offering fake vaccine sales due to delays in the supply of Kovid-19 vaccines. The OLAF said in a statement on Monday that a number of reports have been brought to its notice in which total people are committing fraud by offering vaccine supplies to EU governments attempting to accelerate the Kovid-19 vaccination.